Skip to main content

Table 2 Local control and overall survival according to stage and chemotherapy regimen

From: A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus

Characteristics Total TS PF p value
Stage II N = 50 N = 28 N = 22  
5-year LC 60.1% 64.8% 53.9% 0.526
5-year OS 35.7% 40.5% 32.4%  
Median survival 32.1 months 30.8 months 35.1 months 0.855
Stage III N = 90 N = 26 N = 64  
5-year LC 53.3% 56.6% 49.6% 0.244
5-year OS 32.3% 47.1% 25.9%  
Median survival 24.0 months 42.4 months 14.6 months 0.015
Total N = 140    
5-year LC 55.9% 61.2% 51.1% 0.185
5-year OS 33.4% 44.3% 27.4%  
Median survival 29.5 months 37.7 months 18.6 months 0.025